12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Monday's intraday session, several healthcare stocks experienced significant movements. Fresh2 Group, Akso Health Group, ChromaDex, Elicio Therapeutics, Immuneering, and Biotricity saw their stock prices increase, with gains ranging from 21.08% to 41.7%. Conversely, Trxade Health, Envoy Medical, CareMax, Titan Pharma, Cargo Therapeutics, and Molecular Templates faced declines, with their stock prices dropping between 17.28% and 33%. CareMax's Q4 earnings were also released.
March 18, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's stock increased by 29.0% to $1.29, with a market cap of $141.3 million.
A 29% increase indicates strong market performance and could attract more investors in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Biotricity's stock increased by 21.08% to $1.55, with a market cap of $14.5 million.
The 21.08% rise in Biotricity's stock indicates a positive market response, likely boosting short-term investor interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
ChromaDex's stock rose by 27.91% to $3.07, with a market cap of $231.1 million.
The substantial increase in ChromaDex's stock price could indicate positive developments, likely enhancing short-term trading volume.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Elicio Therapeutics' stock increased by 24.0% to $6.2, with a market value of $59.5 million.
A 24% rise in stock price suggests investor confidence, potentially leading to more interest and investment in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Fresh2 Group's stock rose 41.7% to $0.66, with a market value of $15.7 million.
The significant price increase suggests positive investor sentiment or favorable news, likely to boost short-term interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Immuneering's stock rose by 23.04% to $2.35, with a market cap of $68.8 million.
The increase in Immuneering's stock price could reflect positive market reception or news, likely to attract short-term trading interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
CareMax's shares decreased by 25.28% to $4.14, with a market value of $15.5 million. Q4 earnings were released.
The 25.28% decline following Q4 earnings release suggests the results may not have met market expectations, likely affecting short-term stock performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
Envoy Medical's shares declined by 27.6% to $3.62, with a market value of $70.7 million.
The 27.6% drop in Envoy Medical's stock price could indicate adverse developments, likely affecting short-term investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Cargo Therapeutics' stock declined by 17.67% to $25.75, with a market cap of $1.0 billion.
The 17.67% decline in Cargo Therapeutics' stock suggests negative market sentiment, likely affecting short-term interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Trxade Health's shares declined by 33.0% to $19.3, with a market value of $23.2 million.
A 33% decline in Trxade Health's stock price suggests negative market sentiment or news, likely impacting short-term trading negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Molecular Templates' shares fell 17.28% to $2.27, with a market value of $12.2 million.
A 17.28% drop in Molecular Templates' stock price indicates a negative market response, likely impacting short-term trading dynamics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Titan Pharma's shares fell 18.34% to $7.59, with a market value of $5.7 million.
An 18.34% decrease in Titan Pharma's stock price indicates negative market reaction, likely impacting short-term trading.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90